Month: October 2026
Ivermectin in Dermatology: Evidence and Controversy
Ivermectin, a macrocyclic lactone developed as a veterinary antiparasitic, is now a staple of dermatologic practice in Florida. It paralyzes and kills invertebrate parasites by binding glutamate-gated chloride channels, and it also appears to have anti-inflammatory effects on human skin. Established uses Oral ivermectin is a first-line treatment for scabies, usually given as two doses …
Continue reading “Ivermectin in Dermatology: Evidence and Controversy”



